HBMD expands impurity reference catalog to 438 standards across 70+ APIs
The updated 2026 catalog adds reference standards covering Acebutolol, Aripiprazole, Bortezomib, Cinnarizine, Fluphenazine HCl and Ziprasidone — alongside dozens more end-use APIs. Every product is backed by ¹H-NMR, HPLC, MS and full Certificate of Analysis, ICH Q3A/Q3B-compliant, and ready for regulatory submissions.
Browse Catalog